» Articles » PMID: 36897508

Brain Metastasis in Breast Cancer: Focus on Genes and Signaling Pathways Involved, Blood-brain Barrier and Treatment Strategies

Overview
Specialty Oncology
Date 2023 Mar 10
PMID 36897508
Authors
Affiliations
Soon will be listed here.
Abstract

Breast cancer (BC) is one of the most prevalent types of cancer in women. Despite advancement in early detection and efficient treatment, recurrence and metastasis continue to pose a significant risk to the life of BC patients. Brain metastasis (BM) reported in 17-20 percent of BC patients is considered as a major cause of mortality and morbidity in these patients. BM includes various steps from primary breast tumor to secondary tumor formation. Various steps involved are primary tumor formation, angiogenesis, invasion, extravasation, and brain colonization. Genes involved in different pathways have been reported to be associated with BC cells metastasizing to the brain. ADAM8 gene, EN1 transcription factor, WNT, and VEGF signaling pathway have been associated with primary breast tumor; MMP1, COX2, XCR4, PI3k/Akt, ERK and MAPK pathways in angiogenesis; Noth, CD44, Zo-1, CEMIP, S0X2 and OLIG2 are involved in invasion, extravasation and colonization, respectively. In addition, the blood-brain barrier is also a key factor in BM. Dysregulation of cell junctions, tumor microenvironment and loss of function of microglia leads to BBB disruption ultimately resulting in BM. Various therapeutic strategies are currently used to control the BM in BC. Oncolytic virus therapy, immune checkpoint inhibitors, mTOR-PI3k inhibitors and immunotherapy have been developed to target various genes involved in BM in BC. In addition, RNA interference (RNAi) and CRISPR/Cas9 are novel interventions in the field of BCBM where research to validate these and clinical trials are being carried out. Gaining a better knowledge of metastasis biology is critical for establishing better treatment methods and attaining long-term therapeutic efficacies against BC. The current review has been compiled with an aim to evaluate the role of various genes and signaling pathways involved in multiple steps of BM in BC. The therapeutic strategies being used currently and the novel ones being explored to control BM in BC have also been discussed at length.

Citing Articles

The LINC00957/miR-17-5p axis regulates the cell cycle and migration in glioblastoma via the cuproptosis-related gene nephronectin.

Duan R, Zhao X, Hong Z, Yu L Transl Cancer Res. 2024; 13(9):4923-4937.

PMID: 39430842 PMC: 11483365. DOI: 10.21037/tcr-24-450.


Association of Granulocyte Colony-Stimulating Factor Treatment with Risk of Brain Metastasis in Advanced Stage Breast Cancer.

Tai Y, Leung J, Wang S, Leung H, Chan A Int J Mol Sci. 2024; 25(19).

PMID: 39409083 PMC: 11477282. DOI: 10.3390/ijms251910756.


Immunotherapy revolutionizing brain metastatic cancer treatment: personalized strategies for transformative outcomes.

Li T, Sun S, Li Y, Zhang Y, Wei L Front Immunol. 2024; 15:1418580.

PMID: 39136027 PMC: 11317269. DOI: 10.3389/fimmu.2024.1418580.


High expression of SULF1 is associated with adverse prognosis in breast cancer brain metastasis.

Li Y, Feng T, Wang Q, Wu Y, Wang J, Zhang W Animal Model Exp Med. 2024; 8(1):162-170.

PMID: 38590118 PMC: 11798736. DOI: 10.1002/ame2.12406.


Breast Tumor Metastasis and Its Microenvironment: It Takes Both Seed and Soil to Grow a Tumor and Target It for Treatment.

Bonni S, Brindley D, Chamberlain M, Daneshvar-Baghbadorani N, Freywald A, Hemmings D Cancers (Basel). 2024; 16(5).

PMID: 38473273 PMC: 10931297. DOI: 10.3390/cancers16050911.


References
1.
Yadav U, Ansari A, Arora S, Joshi G, Singh T, Kaur H . Design, synthesis and anticancer activity of 2-arylimidazo[1,2-a]pyridinyl-3-amines. Bioorg Chem. 2021; 118:105464. DOI: 10.1016/j.bioorg.2021.105464. View

2.
Yadav U, Singh T, Kumar P, Sharma P, Kaur H, Sharma S . Metabolic Adaptations in Cancer Stem Cells. Front Oncol. 2020; 10:1010. PMC: 7330710. DOI: 10.3389/fonc.2020.01010. View

3.
Parsa N . Environmental factors inducing human cancers. Iran J Public Health. 2013; 41(11):1-9. PMC: 3521879. View

4.
Li X, Wang J . Mechanical tumor microenvironment and transduction: cytoskeleton mediates cancer cell invasion and metastasis. Int J Biol Sci. 2020; 16(12):2014-2028. PMC: 7294938. DOI: 10.7150/ijbs.44943. View

5.
Hosonaga M, Saya H, Arima Y . Molecular and cellular mechanisms underlying brain metastasis of breast cancer. Cancer Metastasis Rev. 2020; 39(3):711-720. PMC: 7497304. DOI: 10.1007/s10555-020-09881-y. View